|

A Registry of AL Amyloidosis (ReAL)

RECRUITINGSponsored by Fondazione IRCCS Policlinico San Matteo di Pavia
Actively Recruiting
SponsorFondazione IRCCS Policlinico San Matteo di Pavia
Started2020-02-27
Est. completion2025-05
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04839003

Summary

The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

1. diagnosis of systemic AL amyloidosis;
2. treatment-naïve (pre-treatment data collected at participating center available for retrospective part);
3. age ≥18 years;
4. ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
5. planned (or ongoing) follow-up at participating center.

Exclusion Criteria:

1. non-AL amyloidosis;
2. previous treatment for AL amyloidosis.

Conditions2

AL AmyloidosisCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.